Route 92 Medical Reperfusion for Acute Ischemic Stroke
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Recruiting
Phase 4
Interventional Study
Acute Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 500 (estimated)
- Sponsor
- Route 92 Medical, Inc. · Industry
Who this trial is looking for
This trial is looking for patients who have had an acute ischemic stroke and have been treated with a specific medical procedure called the Route 92 Medical Reperfusion System. Participants will need to provide consent within 72 hours after their treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I have had an acute ischemic stroke
- I have been treated with the Route 92 Medical Reperfusion System
- I completed informed consent within 72 hours after treatment
- Endovascular treatment started within 8 hours from when I was last known well
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
* Informed consent completed and documented within 72 hours following thrombectomy procedure
* Endovascular treatment initiated (defined as time of groin puncture) within 8 …
Contacts